Legal-Bay Pre Settlement Funding Announces Entry into Polinsky Sex Abuse Lawsuit Funding

As hernia mesh lawsuits continue to progress against major medical device manufacturers, Mayfair Legal Funding is stepping forward with financial solutions to support plaintiffs awaiting settlements. As a trusted provider of pre-settlement funding, Mayfair is committed to helping victims of defective hernia mesh implants manage their financial needs while pursuing justice.

Hernia Mesh Lawsuits and Manufacturer Liability

Hernia mesh implants, designed to provide long-term repair for hernias, have been linked to severe complications such as chronic pain, infections, adhesion, and organ perforation. Many affected individuals have filed lawsuits against manufacturers like C.R. Bard, Ethicon (a Johnson & Johnson subsidiary), and Medtronic, alleging that their mesh products were defectively designed and failed to provide the promised benefits.

The legal process for these cases is extensive, with thousands of plaintiffs waiting for settlements. A significant development occurred in October 2024 when C.R. Bard reached a settlement agreement involving approximately 38,000 lawsuits, though financial relief for many plaintiffs is still pending. As litigation continues, Mayfair Legal Funding is ensuring that victims are not forced into premature settlements due to financial strain.

Providing Relief During Lengthy Legal Proceedings

Hernia mesh complications can result in multiple surgeries, chronic pain, infections, and organ damage, significantly affecting victims' quality of life. However, proving liability in court is a complex process that can extend for years. Manufacturers and their insurers frequently employ delaying tactics, making it difficult for plaintiffs to maintain financial stability while waiting for a fair settlement.

Many individuals who file lawsuits cannot work due to their medical conditions, yet they must continue paying for essential needs, ongoing healthcare, and legal costs. The prolonged nature of these lawsuits means that victims are often financially pressured to settle prematurely, even if their case could result in higher compensation with more time.

Why Legal Funding Matters

The pressure to settle early for a lower amount is common in hernia mesh litigation. Insurance companies and medical device manufacturers often attempt to delay proceedings, making it difficult for plaintiffs to maintain financial stability. Lawsuit loans allow plaintiffs to access a portion of their expected settlement upfront, helping cover urgent expenses such as medical treatments, rent, utilities, and other living costs. This financial support ensures that plaintiffs are not forced into disadvantageous settlements due to economic pressure.

Eligibility and Application Process

Plaintiffs who have filed a hernia mesh lawsuit and are represented by an attorney may be eligible for funding. Mayfair Legal Funding works closely with law firms handling hernia mesh cases to ensure that plaintiffs can access financial assistance without delays.

About Mayfair Legal Funding

Mayfair Legal Funding is a trusted provider of pre-settlement funding, helping plaintiffs in medical device lawsuits, including hernia mesh cases, stay financially stable while awaiting settlements. With a risk-free, non-recourse funding model, plaintiffs only repay if they win their case. Mayfair ensures fast approvals, access to funds within 24 hours, and no credit checks. To date, the company has provided $45 million in funding with a 94% approval rate.

Deminor, a leading global litigation funder, is pleased to announce the successful completion of a EUR 100 million funding round. The proceeds will be used to support the continued expansion of Deminor’s litigation portfolio across its three core regions: Continental Europe, the UK and Asia.

Next to this major funding milestone, Deminor has also achieved the “Certified B Corporation™” status, becoming the first litigation funder outside the US to do so. This certification highlights the company’s commitment to high standards of social and environmental performance, transparency, and accountability.

1. Over the past few years, Deminor has significantly diversified its portfolio in terms of both claim types and geographic reach. Originally focused on securities actions for investors in Continental Europe, Deminor now finances a broad range of claims, including competition and antitrust cases, collective consumer actions and commercial litigation/arbitration throughout its three core regions: Continental Europe, the UK and Asia.

The firm currently funds 47 active cases and has funded a total of 85 cases across 23 jurisdictions. Notably, 78.8% of all concluded cases have resulted in positive outcomes for clients—reflecting Deminor’s disciplined case selection and prudent risk management approach.

Deminor also leverages a proprietary digital platform to deliver technology-driven solutions for managing mass claims in areas such as securities, antitrust, and consumer law.

2. The latest investment round of EUR 100 million, comprising equity, senior and junior debt, and asset-backed financing, includes participation from a diverse group of investors. These include Contingency Capital LLC (New York), which provided a EUR 72 million (USD 80 million) secured credit facility to the company, alongside finance&invest.brussels SA (backed by the Brussels regional government and local financial institutions), Stalusa (a Belgian family office), and Saffelberg Investments (a Belgian private equity firm). Existing shareholders, including Deminor’s management team, also participated in the round.

Despite challenging market conditions and regulatory uncertainty in 2023 and 2024, the legal finance sector remains resilient and is expected to record strong growth in 2025 and beyond. Key drivers include growing market awareness, restricted corporate credit access, and a rising number of collective actions by both businesses and consumers.

3. As the first litigation funder outside the USA to achieve B Corp certification, Deminor reaffirms its mission as a value-driven organization. High ethical standards have always guided its investment strategy, and the firm is proud to support claimants who might otherwise lack access to justice. Deminor believes this approach promotes a more balanced legal landscape and contributes to a fairer economy and society.

About Deminor: 

Founded in 1990, Deminor is a Band 1 Chambers & Partners international litigation funder with offices in Brussels, London, Hamburg, New York, Hong Kong, Madrid, Milan, Stockholm and Luxembourg. Deminor’s name, derived from the French ‘défense des minoritaires’, reflects its origins in providing services to minority shareholders. Deminor is still very much defined by the pursuit of good causes and its determination to restore justice for clients. 

Combining skill sets from 19 different nationalities and 22 languages, Deminor has actively supported cases in 23 different jurisdictions, including the Americas, the Middle East and offshore centres such as the Cayman Islands and Bermuda. 

In addition to funding one-to-one commercial claims, Deminor originates, syndicates and funds group actions. In 2018, Deminor was instrumental in securing the two largest securities settlements in Europe (EUR 1.4 bn in the Steinhoff case and EUR 1.3 bn in Fortis/Ageas).